Detalhe da pesquisa
1.
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Lancet
; 403(10426): 533-544, 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310910
2.
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023.
Biologicals
; 85: 101745, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341355
3.
Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023.
Biologicals
; 85: 101747, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350825
4.
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies.
Malar J
; 22(1): 159, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208733
5.
Malaria hospitalisation in East Africa: age, phenotype and transmission intensity.
BMC Med
; 20(1): 28, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081974
6.
Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.
Malar J
; 21(1): 159, 2022 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35655174
7.
Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.
Virol J
; 18(1): 28, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33499880
8.
Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea.
Malar J
; 20(1): 322, 2021 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34284778
9.
Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children.
N Engl J Med
; 374(26): 2519-29, 2016 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27355532
10.
Detection of malaria parasites in dried human blood spots using mid-infrared spectroscopy and logistic regression analysis.
Malar J
; 18(1): 341, 2019 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590669
11.
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
N Engl J Med
; 368(12): 1111-20, 2013 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23514288
12.
CD4+ T cell responses to the Plasmodium falciparum erythrocyte membrane protein 1 in children with mild malaria.
J Immunol
; 192(4): 1753-61, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24453249
13.
Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity.
BMC Med
; 13: 114, 2015 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25967134
14.
Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children.
Proc Natl Acad Sci U S A
; 109(21): 8247-52, 2012 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22566630
15.
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.
BMC Med
; 12: 117, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25012228
16.
Child Health and Infection with Low Density (CHILD) malaria: a protocol for a randomised controlled trial to assess the long-term health and socioeconomic impacts of testing and treating low-density malaria infection among children in Tanzania.
BMJ Open
; 14(3): e082227, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538037
17.
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
Lancet Infect Dis
; 24(5): 465-475, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342107
18.
Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
BMC Med
; 11: 184, 2013 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23962071
19.
Feedback of research findings for vaccine trials: experiences from two malaria vaccine trials involving healthy children on the Kenyan Coast.
Dev World Bioeth
; 13(1): 48-56, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23433355
20.
Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data.
PLoS One
; 18(9): e0291244, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708143